CCRM

Toronto, ON
National Center
Cell Therapy mRNA
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
78.1
Signal Score
✓ FDA Inspections (5) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: CCRM

Signal Score
78.1/100 (as of 2026-04-29)
Quality Compliance
100.0/100 — Bonus: 5 consecutive NAI inspections
Headquarters
Toronto, ON
Modalities
Cell Therapy, mRNA
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About CCRM

CDMO.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
Bonus: 5 consecutive NAI inspections
Source: FDA Data Dashboard
Bonus: 5 consecutive NAI inspections
FDA Inspections5 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-09-04)
Bonus: 5 consecutive NAI inspections
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesCell Therapy, mRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 manufacturing site: Toronto, ON
Modalities: Cell Therapy, mRNA
Capacity assessment: 58.0/100
Sites: Toronto, ON
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Toronto, ON
Modalities: Cell Therapy, mRNA
Capacity assessment: 58.0/100

CCRM FDA Inspection History

2025-09
2025-08
2025-07
2025-03
2025-03
NAI VAI OAI
Date Site Type Observations Classification
2025-09-04 Frisco, Texas Human Cellular, Tissue, and Gene Therapies No No Action Indicated (NAI)
2025-08-21 Chestnut Hill, Massachusetts Human Cellular, Tissue, and Gene Therapies No No Action Indicated (NAI)
2025-07-22 Edina, Minnesota Human Cellular, Tissue, and Gene Therapies No No Action Indicated (NAI)
2025-03-27 Menlo Park, California Human Cellular, Tissue, and Gene Therapies No No Action Indicated (NAI)
2025-03-21 New York, New York Human Cellular, Tissue, and Gene Therapies No No Action Indicated (NAI)
Source: FDA Data Dashboard · Retrieved Jul 04, 2026

Frequently Asked Questions About CCRM

How many FDA inspections does CCRM have on record?
CDMO Signal tracks 5 FDA inspections for CCRM, sourced from the FDA inspection database. See the full inspection history above.
Has CCRM received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for CCRM.
What is CCRM's CDMO Signal Score?
CCRM has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating CCRM for a manufacturing program?
Use the free AI matchmaker to compare CCRM against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Cell Therapy CDMOs → mRNA CDMOs →

Similar CDMOs

Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Danaher (CGT Portfolio)
Washington, DC
Signal Score: 81.5
Cell Therapy, AAV, mRNA
Lonza
Basel, Switzerland
Signal Score: 78.2
AAV, Lentiviral, Cell Therapy, mRNA, ADC, Monoclonal Antibody, Recombinant Protein
Cytiva (Mfg Services)
Marlborough, MA · Uppsala, SE
Signal Score: 74.0
Cell Therapy, AAV, mRNA
National Resilience
San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
Signal Score: 73.4
mRNA, Gene Therapy, Cell Therapy